Literature DB >> 30136236

Analyzing Necroptosis Using an RIPK1 Kinase Inactive Mouse Model of TNF Shock.

Matija Zelic1, Michelle A Kelliher2.   

Abstract

The serine/threonine kinase RIPK1 has numerous biological and pathological functions, mediating prosurvival as well as prodeath apoptotic and necroptotic signaling pathways downstream of various receptors, including death receptors and Toll-like receptors (TLRs). RIPK1 has been implicated in various diseases, including ischemia-reperfusion injury and inflammatory bowel disease (IBD). The recent generation of RIPK1 kinase inactive mice has enabled us to genetically interrogate the role of RIPK1 kinase-mediated necroptosis in disease models. Here, we describe procedures utilizing kinase inactive Ripk1D138N/D138N mice to analyze necroptosis induction in vitro in bone-marrow derived macrophages (BMDMs) and in vivo in a murine model of TNF-induced shock.

Entities:  

Keywords:  Bone marrow-derived macrophages; Caspase inhibitor; Cell death; Lipopolysaccharide; Necroptosis; TNF shock

Mesh:

Substances:

Year:  2018        PMID: 30136236      PMCID: PMC7250063          DOI: 10.1007/978-1-4939-8754-2_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  16 in total

Review 1.  Sexual dimorphism in innate immune responses to infectious organisms.

Authors:  Ian Marriott; Yvette M Huet-Hudson
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury.

Authors:  Alexei Degterev; Zhihong Huang; Michael Boyce; Yaqiao Li; Prakash Jagtap; Noboru Mizushima; Gregory D Cuny; Timothy J Mitchison; Michael A Moskowitz; Junying Yuan
Journal:  Nat Chem Biol       Date:  2005-05-29       Impact factor: 15.040

3.  Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL.

Authors:  William J Kaiser; Haripriya Sridharan; Chunzi Huang; Pratyusha Mandal; Jason W Upton; Peter J Gough; Clark A Sehon; Robert W Marquis; John Bertin; Edward S Mocarski
Journal:  J Biol Chem       Date:  2013-09-09       Impact factor: 5.157

Review 4.  Necroptosis in development, inflammation and disease.

Authors:  Ricardo Weinlich; Andrew Oberst; Helen M Beere; Douglas R Green
Journal:  Nat Rev Mol Cell Biol       Date:  2016-12-21       Impact factor: 94.444

5.  The death domain kinase RIP mediates the TNF-induced NF-kappaB signal.

Authors:  M A Kelliher; S Grimm; Y Ishida; F Kuo; B Z Stanger; P Leder
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

6.  Identification of RIP1 kinase as a specific cellular target of necrostatins.

Authors:  Alexei Degterev; Junichi Hitomi; Megan Germscheid; Irene L Ch'en; Olga Korkina; Xin Teng; Derek Abbott; Gregory D Cuny; Chengye Yuan; Gerhard Wagner; Stephen M Hedrick; Scott A Gerber; Alexey Lugovskoy; Junying Yuan
Journal:  Nat Chem Biol       Date:  2008-05       Impact factor: 15.040

7.  Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo.

Authors:  Apostolos Polykratis; Nicole Hermance; Matija Zelic; Justine Roderick; Chun Kim; Trieu-My Van; Thomas H Lee; Francis K M Chan; Manolis Pasparakis; Michelle A Kelliher
Journal:  J Immunol       Date:  2014-07-11       Impact factor: 5.422

8.  Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice.

Authors:  Scott B Berger; Viera Kasparcova; Sandy Hoffman; Barb Swift; Lauren Dare; Michelle Schaeffer; Carol Capriotti; Michael Cook; Joshua Finger; Angela Hughes-Earle; Philip A Harris; William J Kaiser; Edward S Mocarski; John Bertin; Peter J Gough
Journal:  J Immunol       Date:  2014-05-12       Impact factor: 5.422

9.  Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models.

Authors:  N Takahashi; L Duprez; S Grootjans; A Cauwels; W Nerinckx; J B DuHadaway; V Goossens; R Roelandt; F Van Hauwermeiren; C Libert; W Declercq; N Callewaert; G C Prendergast; A Degterev; J Yuan; P Vandenabeele
Journal:  Cell Death Dis       Date:  2012-11-29       Impact factor: 8.469

Review 10.  Gender differences in sepsis: cardiovascular and immunological aspects.

Authors:  Martin K Angele; Sebastian Pratschke; William J Hubbard; Irshad H Chaudry
Journal:  Virulence       Date:  2013-11-05       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.